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Abstract
Objective
To validate the current criteria of visual snow and to describe its common phenotype using
a substantial clinical database.
Methods
We performed a web-based survey of patients with self-assessed visual snow (n = 1,104), with
either the complete visual snow syndrome (n = 1,061) or visual snow without the syndrome
(n = 43). We also describe a population of patients (n = 70) with possible hallucinogen
persisting perception disorder who presented clinically with visual snow syndrome.
Results
The visual snow population had an average age of 29 years and had no sex prevalence. The
disorder usually started in early life, and ≈40% of patients had symptoms for as long as they
could remember. The most commonly experienced static was black and white. Floaters,
afterimages, and photophobia were themost reported additional visual symptoms. A latent class
analysis showed that visual snow does not present with specific clinical endophenotypes.
Severity can be classified by the amount of visual symptoms experienced. Migraine and tinnitus
had a very high prevalence and were independently associated with a more severe presentation
of the syndrome.
Conclusions
Clinical characteristics of visual snow did not differ from the previous cohort in the literature,
supporting validity of the current criteria. Visual snow likely represents a clinical continuum,
with different degrees of severity. On the severe end of the spectrum, it is more likely to present
with its common comorbid conditions, migraine and tinnitus. Visual snow does not depend on
the effect of psychotropic substances on the brain.
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Visual snow (VS) is a recently identified neurologic condition
consisting of a constant positive visual disturbance described as
uncountable tiny dots over the entire visual field1 (figure 1). In
addition to the static, patients very often report visual symp-
toms such as palinopsia, entoptic phenomena, photophobia,
and nyctalopia. This constitutes the VS syndrome (VSS),
which is outlined by a set of specific criteria (table 1).2 From the
first case report of VS by Liu et al.3 in 1995, the recognition of
the disorder has grown considerably, to the point where VS is
now included in the appendix of the International Classification
of Headache Disorders as a complication of migraine.4
Several questions concerning VS have arisen as the condition
has become better known. For example, if there is a need to
define the differences between VS and the presentation as
a “complete” syndrome? What are its most common clinical
phenotypes, and what is the relationship with other comorbid
conditions? Similarly, given that hallucinogenics can produce
a similar disturbance,5 are there clinical distinctions that may
inform understanding the biology involved?
Here, we describe the clinical characteristics of a substantial
population of patients with VS, both with and without the
complete VSS. Our main objective was to test the current
criteria and to confirm the typical presentation of the main
symptom of VS—i.e., the static—in the context of a larger
cohort and to begin to determine any broad differences re-
lated to geography. We also wanted to explore a dataset large
enough to dissect possible subgroups and endophenotypes.
Finally, we wished to observe the interaction between VS and
its main comorbid conditions migraine and tinnitus and to
compare the disturbance with patients with hallucinogen
persisting perception disorder (HPPD).
Methods
Participant selection and recruitment
The study was advertised on the website of Eye On Vision
(eyeonvision.org/), a patient self-help group for VS with whom
we have collaborated.Most of the patients involved in the study
approached our group through a dedicated research e-mail,
which they could find on the website. A smaller number of
patients had contacted the researchers individually asking to be
involved in research and were redirected to the website.
An online survey was prepared in collaboration with the patient
group and was made available on the Eye On Vision website.
The survey is illustrated in table 2; it presents a series of open and
dichotomous questions aimed to characterize the symptoms of
VS following the available criteria. We also investigated the
presence ofmigraine and tinnitus. Finally, we enquired about age
at symptom onset and previous exposure to recreational drugs.
The study was approved by the KCL Research Ethics Panel.
Data were collected between April 2016 and May 2018.
Figure 1 Illustration of visual snow
Glossary
DSM-V = Diagnostic and Statistical Manual of Mental Disorders, 5th edition; HPPD = hallucinogen persisting perception
disorder; VS = visual snow; VSS = visual snow syndrome.
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Patient characterization
Following the 2014 criteria (table 1), we defined patients who
self-reported visual symptoms corresponding to criterion A
(as evaluated by responses to questions 2–4 of our survey)
and who also fit criterion B (as evaluated by responses to
question 5 in our survey) as having VSS. Criteria C and D
were evaluated on a case-to-case basis on the basis of answers
to questions 2, 6, and 7 and eventual follow-up questions by
the investigators when in doubt. Patients who did not report
>2 additional visual symptoms of the 4 main categories,
therefore lacking criterion B, but who fit all the other criteria
were considered to have VS without the syndrome.
To avoid confounding with HPPD, patients who answered
“yes” to question 7 in our survey were further followed up with
in-depth questions aimed at assessing when their symptoms
appeared with respect to the intake of recreational drugs. All
participants who reported the onset of VS symptoms in the 12
months after any exposure to recreational drugs were excluded
from the first 2 groups, regardless of the remaining symptoms,
and were added to a third group called possible HPPD. All
participants in this third group fit criterion A for typical VS and
were therefore included in the analysis.
All data collection and patient characterization were per-
formed by one of us (F.P.).
Statistical analysis
Data were tabulated (Excel 2016 for Windows). Descriptive
statistics, analysis of variance, or χ2 analysis for comparisons of
continuous and categorical variables and cluster analysis were
performedwith SPSS Statistics Version 24.0 forWindows (IBM
Corp, Armonk, NY). Regression analysis, multiple imputations,
and latent class analysis were performed in Stata (Stata Statis-
tical Software release 15, 2017, StataCorp LLC, College Station,
TX). Values of p < 0.05 were considered significant.
We separated patients into 3 different groups according to their
diagnosis: patients with VSS were coded as group 1, patients
with VS as group 2, and patients with HPPD as group 3.
An ordinal variable was created to measure disease severity
according to the number of visual symptoms experienced. For
the largest cohort (i.e., group 1), this outcome variable was
regressed on selected variables using ordinal logistic re-
gression. The variables included as covariates in this model
were selected in a previous step based on a correlation with
the number of symptoms experienced defined by significant
correlations at the 5% level using the Spearman correlation.
A latent class analysis was performed to investigate possible
endophenotypes of VS, first on group 1 only and then on
groups 1 and 2 combined.
Data availability
The data that support the findings of this study are available
from the corresponding author on reasonable request.
Results
Demographic characteristics
From April 2016 to May 2018, patients (n = 1,400) contacted
the study group through the e-mail designated to VS research.
Of these, 210 either gave incomplete data in the initial survey
Table 1 Criteria for the definition of the visual snow syndrome
A. Visual snow: dynamic, continuous, tiny dots in the entire visual field lasting >3 mo.
The dots are usually black/gray on white background and gray/white on black background; however, they can also be transparent, white flashing, or
colored.
B. Presence of at least 2 additional visual symptoms of the 4 following categories:
(i) Palinopsia. At least 1 of the following: afterimages or trailing of moving objects.
Afterimages should be different from retinal afterimages, which occur only when staring at a high-contrast image and are in complementary color.
(ii) Enhanced entoptic phenomena. At least 1 of the following: excessive floaters in both eyes, excessive blue field entoptic phenomenon, self-light of the
eye, or spontaneous photopsia.
Entoptic phenomena arise from the structure of the visual system itself. The blue field entoptic phenomenon is described as uncountable little gray/
white/black dots or rings shooting over the visual field in both eyes when looking at homogeneous bright surfaces such as the blue sky; self-light of the
eye is described as colored waves or clouds when closing the eyes in the dark; spontaneous photopsia is characterized by bright flashes of light.
(iii) Photophobia.
(iv) Nyctalopia.
C. Symptoms are not consistent with typical migraine visual aura.
As defined by the International Headache Society in the International Classification of Headache Disorders.4
D. Symptoms are not better explained by another disorder.
Normal ophthalmology tests (best corrected visual acuity, dilated fundus examination, visual field, and electroretinogram); not causedby previous intake of
psychotropic drugs.
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or never replied after having been redirected to the patient
website; these individuals were excluded from further data
collection. Two individuals had an insufficient English level; 6
had a serious underlying ophthalmic condition; and 8 did not
fulfill criterion A, meaning the static they reported either was
of episodic nature or was present in only 1 part of the visual
field. These patients were all excluded from the analysis.
Demographic characteristics of the remaining participants (n
= 1,174) are presented in table 3, which also shows details of
symptom onset and associated comorbid conditions. The
majority of the cohort (n = 1,061, 90%) had complete VSS.
Forty-three participants in the cohort were considered to have
VS alone because they provided a very clear description of the
dynamic continuous pan-field tiny dots described in criterion
A. These participants, however, did not present at least 2 visual
symptoms from the additional categories and were grouped in
the VS category. Of these, 7 participants had no additional
symptoms, 20 had only 1 symptom, and 16 had between 2 and
4 symptoms of the same category, e.g., palinopsia for stationary
objects and trailing or several entoptic phenomena.
Seventy participants were grouped as possible HPPD following
the criteria previously described.1 With the exception of expo-
sure to recreational drugs in the 12 months before the onset of
symptoms, they all had the remaining criteria for VSS diagnosis.
Features of the disorder in the cohorts and
comparison to HPPD
In table 3, the 3 groups are compared among themselves and
with the cohort from the 2014 study, when the required data
were available. The 4 groups did not differ with regard to age.
Male and female ratios were similar for participants with VS
(VSS and VS); however, in the HPPD population, most
patients (71%; p < 0.001) were male. The large majority of
participants came from North America (n = 429, 41% for VSS;
n = 23, 54% for VS; n = 21, 31% for HPPD) and Europe (n =
497, 48% for VSS; n = 15, 35% for VS; n = 41, 61% for HPPD).
Participants with HPPD had a significantly later onset of
symptoms compared to patients with VS, both with and with-
out the syndrome (p < 0.001). As a consequence, the average
years with diseasewere lower in theHPPDgroup (p< 0.001). A
small number (n = 99) of participants in the VSS group
reported a clear stepwise worsening of symptoms at some point
of the condition; however, this feature was not routinely
screened for, so it is not possible to infer its actual prevalence.
Forty percent of patients with VSS for whom data on onset age
were available reported the presence of symptoms since child-
hood, meaning for as long as they could recall. This was higher
than the proportion found in the 2014 study. About one-quarter
of the participants with VS (VSS and VS) reported a sudden
onset of their symptoms; however, the real frequency of this
form of onset might be different because participants were not
interrogated about it directly. Of these spontaneous reports of
sudden onset, some were related to specific conditions in-
dicated in the table 3; a migraine attack was the most frequent.
In the majority of cases, however, the participants could not
recall any specific associated event. A sudden onset of symp-
toms was significantly more frequent in theHPPD group (81%;
p < 0.001). By definition, all of these patients had the start of
symptoms within a year after using recreational drugs. Four of
these participants could also recall other specific events (i.e., a
migraine attack, a new medication, and a mild head trauma) in
strict temporal relation to the beginning of their symptoms.
Tinnitus and migraine
The presence of tinnitus in the VSS population was the highest
but overall similar to that of the HPPD and 2014 cohorts. The
frequency of this symptom was, however, significantly lower in
the VS group compared to the others. This was also the case for
migraine, which was significantly less frequent in the VS
Table 2 Online survey (available on eyeonvision.org/)
Name
Address
Date of birth (day/month/year)
Telephone number
(1) Please make a brief statement that you are willing to be contacted for
research. This is a European data protection issue. Example: “Yes, please
keep my contact details, and you may contact me for research purposes.”
(2) Brief description of all symptoms you relate to visual snow syndrome.
(3) Date or age when your symptoms started.
(4) Visual snow: what type
Black and white (i.e., only black dots on white background, white dots on
black background)
Clear (i.e., color of the background)
Flashing (i.e., always white, brighter than background)
Colored
All of these
(5) Other symptoms (please only answer yes or no)
After images
Trailing of images in the vision
Blue field entoptic phenomenon (i.e., white squiggly lines moving
pulsating on the blue sky)
Floaters in vision
Colored clouds or waves with eyes closed
Flashes of light
Impaired night vision
Sensitive to light
Tinnitus
(6) Have you ever been diagnosed with migraine, or have you had
a headache of moderate or severe intensity in the past? (Please answer yes
or no)
(7) Have you ever taken any illicit drugs in the past?
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population and more frequent in the VSS population. The
presence of migraine aura was not routinely investigated because
we considered this diagnosis unreliable for a dichotomous
questionnaire. It was spontaneously reported in 37%(p= 0.05) of
participants in the VSS group, and in all these cases, the diagnosis
was confirmed with thorough follow-up questions.
Clinical characterization of VS: Static
We collected information on the type of static that patients ex-
perienced and the associated visual symptoms that form the VSS.
Table 4 shows the frequencies of these characteristics, comparing
them across the 3 groups and with the 2014 study cohort.
Each of the 4 static types was reported more frequently in the
VSS group. This is probably accounted for by the fact that this
group had a significantly higher proportion of participants
reporting all 4 types of static. The most common type of static
differed between the VSS and VS groups compared to the
HPPD group. When only 1 type of static was present, this was
most commonly black and white in the VSS and VS groups
and transparent in the HPPD group. When 2 types of static
were present, the most frequent combination was black and
white and transparent for the VSS and VS groups and colored
and flashing for the HPPD group. When 3 types of static were
present, the combination of black and white, flashing, and
Table 3 Demographics, comorbid conditions, and characteristics of symptom onset
VSS VS HPPD Schankin et al.1
Patients, n (% of cohort) 1,061 (90) 43 (4) 70 (6) 78
Age (mean ± SD), y 29.5 ± 10.3 29.4 ± 12.3 27.5 ± 7.2 30 ± 10
Female:male within group, n 521:539 (p = 0.6) 18:25 (p = 0.3) 20:50b 37:41
Region of origin, n (%)
Europe 497 (48) 15 (35) 41 (61)
North America 429 (41) 23 (54) 21 (31)
Central and South America 23 (2) 0 1 (2)
Central Asia and Middle East 28 (3) 1 (2.3) 0
Southeast Asia 17 (2) 1 (2.3) 0
Oceania 49 (5) 3 (7) 4 (6)
Africa 3 (0.3) 0 0
Age at symptom onset (mean ± SD), y 12.8 ± 13.2 8.7 ± 10.2 20.5 ± 6.7b 21 ± 9
Data available, n 823 28 60
Symptoms present since childhood, n (%) 326 (40) 13 (46) 1 (0.01)b 19 (24)
Years of disease (mean ± SD) 17.2 ± 13.6 20.2 ± 16.9 7.1 ± 8.1b —
Stepwise worsening of symptoms, n (%) 99 (9) 0 4 (6) 10 (13)
Sudden onset of symptoms, n/N (%) 176/691 (26) 4/16 (25) 38/47 (81)b
With migraine attack 42/176 — 1/47
With medication 20/176 — 2/47
With trauma 10/176 — 1/47
With infection 10/176 — —
With recreational drugs — — 38 of 47
No apparent cause 94/176 4/16 —
Comorbid conditions, n/N (%)
Tinnitus 793 (75) 18 (42)b 48 (69) 48 (62)
Migraine 557/775 (72) 7/18 (39)b 26/46 (57) 46 (59)
Migraine aura 127/345 (37)a 1/6 (17) 1/10 (10) 21 (27)
Abbreviations: HPPD = hallucinogen persisting perception disorder; VS = visual snow; VSS = visual snow syndrome.
a p < 0.05 measured accordingly by analysis of variance or χ2 tests.
b p < 0.001 measured accordingly by analysis of variance or χ2 tests.
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transparent was the most common in the VSS and VS groups,
whereas the combination of colored flashing and transparent
was the most common in the HPPD group. The 2014 cohort
showed different results from all groups in the present study,
with no patients reporting a combination of >2 types of static.
This could be due to the fact that the current questionnaire
was more flexible on static types, accounting for all types as
defined by criterion A.
Clinical characterization of VS-associated
visual symptoms
With regard to the associated visual symptoms, the VSS and
HPPD groups did not significantly differ with regard to the
mean number of associated visual symptoms reported by
each patient. The 3 most common symptoms in the VSS
group were, in order, floaters, afterimages, and photophobia.
In the VS cohort, the most frequent symptoms were all of
the entoptic phenomena group: floaters, self-light of the eye,
and flashes. In the HPPD group, the 4 most commonly
reported symptoms were afterimages, photophobia, floaters,
and nyctalopia. Taking each symptom separately, the VSS
and HPPD groups did not differ among themselves or with
the 2014 cohort with regard to the frequencies of each
symptom.
Predicting severity based on symptoms:
Ordinal logistic regression
The results are shown in table 5.We first performed a complete
case analysis in which any case with a missing value on either
the outcome or the covariates was omitted from the analysis.
Table 4 VS characteristics and frequencies of associated symptoms
VSS (n = 1,061), n (%)
[95% CI]
VS (n = 43), n (%) [95%
CI]
HPPD (n = 70), n (%)
[95% CI]
Schankin et al.1 (n = 78), n (%)
[95% CI]
Types of static
Black and white static 609 (58) (0.54–0.60)a 17 (40) (0.26–0.54) 30 (44) (0.32–0.55) 34 (44) (0.33–0.55)
Colored static 467 (44) (0.41–0.47)a 11 (26) (0.15–0.40) 26 (38) (0.27–0.49) 15 (19) (0.12–0.29)
Flashing static 495 (47) (0.44–0.50)a 11 (26) (0.15–0.40) 27 (40) (0.28–0.50) 19 (24) (0.16–0.35)
Transparent static 555 (53) (0.49–0.55)a 15 (35) (0.22–0.50) 41 (60) (0.47–0.69) 16 (21) (0.13–0.31)
No. of static types
1 560 (53) (0.5–0.56)a 36 (84) (0.76–0.95) 44 (64) (0.51–0.73) 71 (91) (0.82–0.96)
2 172 (16) (0.14–0.19) 5 (12) (0.05–0.25) 9 (13) (0.07–0.23) 7 (9) (0.04–0.17)
3 70 (7) (0.05–0.08) 0 3 (4) (0.01–0.12) 0
4 253 (24) (0.21–0.27)a 2 (5) (0.01–0.16) 13 (19) (0.11–0.29) 0
Associated visual symptoms
Afterimages 861 (81) (0.79–0.83) 1 (2) (0.00–0.12)b 58 (83) (0.72–0.90) 67 (86) (0.77–0.92)
Trailing 626 (59) (0.56–0.62) 0b 45 (64) (0.53–0.75) 47 (60) (0.50–0.70)
BFEP 704 (67) (0.63–0.69) 7 (16) (0.08–0.30)b 47 (67) (0.56–0.77) 62 (79) (0.70–0.87)
Floaters 906 (86) (0.83–0.87) 19 (44) (0.30–0.59)b 54 (77) (0.66–0.85) 63 (81) (0.71–0.90)
Self-light of the eye 749 (71) (0.68–0.73) 11 (26) (0.15–0.40)b 49 (70) (0.59–0.80) 41 (53) (0.42–0.63)
Flashes 668 (63) (0.60–0.66) 9 (21) (0.11–0.35)b 42 (60) (0.48–0.70) 49 (63) (0.52–0.73)
Nyctalopia 821 (78) (0.75–0.80) 6 (14) (0.07–0.27)b 54 (77) (0.66–0.85) 53 (68) (0.56–0.76)
Photophobia 856 (81) (0.78–0.83) 3 (7) (0.02–0.19)b 56 (80) (0.69–0.880) 58 (74) (0.64–0.83)
Total associated visual
symptoms, n
Mean ± SD 5.8 ± 1.7 1.3 ± 0.95b 5.9 ± 1.9
Median 6.0 1 6.0
IQR 7–5 2–1 8–4.5
Abbreviations: CI = confidence interval; HPPD = hallucinogen persisting perception disorder; IQR = interquartile range; VS = visual snow; VSS = visual snow
syndrome.
Values are number (percentages within groups) (95% CIs of proportions).
a p < 0.05 measured accordingly by analysis of variance or χ2.
b p < 0.001 measured accordingly by analysis of variance or χ2.
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We then performed the same analysis using 10 imputed
datasets in which a chained equations approach was used
and the imputations were stratified by sex. The parameter
estimates were similar across both models. This is un-
surprising because there were no missing data for the
symptoms and the level of missing data was low for most
covariates (<2%) except for disease duration and presence
of migraine. These 2 variables were added later to the data
collection procedure and thus likely to be missing at ran-
dom. One participant for whom sex was not specified was
excluded from the analysis.
The results from the multiply imputed analysis indicated
that female participants were approximately one-third more
likely to experience a higher number of symptoms than male
participants. Those reporting migraine were >2.5 times
more likely to experience a higher number of symptoms,
and those with tinnitus were about twice as likely to expe-
rience a higher number of symptoms. A test for an in-
teraction between migraine and tinnitus was not significant,
indicating that these 2 concomitant conditions exert in-
dependent and additive effects on the number of VS
symptoms experienced. Age, disease duration, and type of
onset were not related to the number of symptoms
experienced.
Latent class analysis
The results of the latent class analysis are shown in table 6 and
figure 2, A and B. This was performed first only on partic-
ipants with VSS (table 6a), with the exclusion of 1 participant
for whom sex was not defined (n = 1,060). Model fit criteria
suggested that a 2-class solution provided the most parsi-
monious explanation of the data, where classes 1 and 2
accounted for x and y of the sample, respectively. The classes
that were obtained separated the patients into groups based
on additional visual symptom frequency. Logistic regression
indicated that the same variables as the ordinal logistic re-
gression for symptom frequency were related to latent class
membership (table 6b).
We then performed the same analysis on participants with
VSS and VS (n = 1,104; table 6c), excluding only those with
HPPD. The analysis showed that a third latent class was
obtained with this further step; however, the model still
showed a group separation based solely on additional visual
symptom frequency.
Discussion
We here describe and analyze a large cohort of patients with
VS. The data support VSS as a well-delineated, clinically
recognizable disorder. Most patients have VS with other visual
symptoms. There is an association with migraine and tinnitus
that is independent, and the condition is clearly not simply
due to hallucinogenic intake. The size of our patient sample
and its provenance from different parts of the world make it
representative of the real population and allow some inference
on several aspects of this condition that should facilitate and
guide further study of the problem.
The results from this study indicate that participants with
VSS are usually young and most commonly present with
black and white or transparent static, as well as a high
number of additional visual symptoms. Even if there is no
specific sex prevalence, identifying with female sex is sig-
nificantly associated with reporting increased severity of the
condition. The visual static can occur in different combina-
tions of color. Visual disturbances can also present in several
Table 5 Ordinal logistic regression of frequency of additional visual symptoms
Complete cases (n = 694) Multiple imputations (n = 1,060)
OR CI OR CI
Age 0.99 0.97–1.01 0.98 0.97–1.00
Female 1.34a 1.02–1.75 1.32a 1.05–1.64
Disease duration 1.00 0.98–1.02 1.00 0.98–1.02
Migraine 2.68b 1.98–3.64 2.67b 1.96–3.64
Tinnitus 2.10b 1.55–2.85 1.98b 1.54–2.55
Onset
From childhood 1.00 — 1.00 —
Later nonsudden 1.10 0.70–1.74 1.03 0.68–1.56
Later sudden 1.02 0.58–1.80 1.03 0.60–1.77
Abbreviations: CI = confidence interval; OR = odds ratio.
a p < 0.05.
b p < 0.001.
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combinations. However, floaters, afterimages, and photo-
phobia are almost invariably present and might in fact con-
stitute a hallmark of the syndrome. The disorder usually
starts in early life, and in many cases, the patients have it
since childhood and can never recall seeing differently. In
these cases, the affected person can find out almost seren-
dipitously about the anomaly in seeing VS, usually by
comparison with unaffected family members or friends. In
a significant number of patients, VS can start abruptly and
spontaneously; however, this is not necessarily related to
a higher number of symptoms in the condition.
This study has shown that once specific criteria are defined
and followed,1 VS is a recognizable disorder, with a very ho-
mogeneous clinical presentation. The description of the pri-
mary symptom (i.e., the static) was highly reproducible across
our cohort, with only a few participants actually presenting
a visual disturbance not attributable to VS. The overall clinical
presentation was also quite similar across our participants (see
previous paragraph) and with the second largest cohort in the
literature,1 albeit with some variations perhaps attributable to
different sample sizes or different methodology. For the 2014
study, patients were in fact interviewed in detail via telephone,
whereas the present study was questionnaire based.
Table 6 Latent class analysis performed on patients with VSS only (a, b; n = 1,060) and on patients with VSS and VS (c; n =
1,104)
1 2 3 4 5 6
(a) Model fit criteria of latent class analysis on patients with VSS
suggested that a 2-class solution provided the most parsimonious
explanation of the data. The classes obtained separated patients
into groups based solely on frequency of additional visual
symptoms.
No. 1,060 1,060 1,060 1,060 1,060 1,060
AIC 9,496.78 9,073.196 9,035.735 9,018.37 9,013.908 9,003.152
BIC 9,536.516 9,157.634a 9,164.876 9,192.214 9,227.488 9,266.401
OR SE z CI
(b) Logistic regression of the latent class analysis for patients with VSS. The same variables were used as in
the ordinal logistic regression in table 5, reinforcing the relationship between frequency of additional
visual symptoms and latent class membership.
Age 0.99 0.009 −0.85 0.97–1.01
Sex 1.3 0.202 1.7 0.96–1.77
Disease-years 0.99 0.010 −0.34 0.98–1.02
Migraine 2.36 0.390 5.18 1.7–3.23
Tinnitus 1.9 0.330 3.7 1.35–2.67
Onset type
1 1.1 0.288 0.31 0.64–1.83
2 0.9 0.284 −0.4 0.466–1.65
1 2 3 4 5 6
(c) Latent class analysis with patients with VSS and VS (n = 1,104).
Model fit criteria of latent class analysis suggested that a 3-class
solution provided the most parsimonious explanation of the data.
An extra class is recovered in the analysis with respect to table 6a;
however, themodel still separated patients into groups based solely
on frequency of additional visual symptoms.
No. 1,104 1,104 1,104 1,104 1,104 1,104
AIC 10,283.85 9,636.164 9,585.471 9,569.977 9,561.652 9,558.281
BIC 10,323.9 9,721.278 9,715.645b 9,745.212 9,781.947 9,823.636
Abbreviations: AIC = Akaike information criterion; BIC = bayesian information criterion; CI = confidence interval; OR = odds ratio; VS = visual snow; VSS = visual
snow syndrome.
Number of observations n = 753; likelihood ratio χ2 = 50.84; probability > χ2 = 0.0000; pseudo R2 = 0.0491; log likelihood = −492.78.
a Two-class solution.
b Three-class solution.
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The current criteria for the syndrome usefully eliminate false-
positive participants. In fact, only a small minority of self-
reporting patients consecutively recruited in the present study
did not fit the full syndrome definition. It is nonetheless im-
portant to recognize the presence of VS in these patients even
in the absence of additional visual disturbances, which both
characterize a higher severity and define the syndrome but are
not a sine qua non for VS itself. In fact, VS is likely to con-
stitute a spectrum type of disorder, with patients ranging in
severity. In this context, a severe end of the spectrum could be
represented by those patients who have the static with all the
visual disturbances and are highly affected by them, and a mild
end could be represented by those who have only static and
are not bothered by it, possibly even considering it normal for
most of their lives. This theory is reinforced by the fact that
VSS and VS did not differ in their key clinical features such as
average age, sex distribution, mode, and age at onset. They
did, however, differ when it came to comorbid conditions,
which were more likely to be found within the syndrome in
patients with a higher number of associated symptoms (i.e., a
more severe condition) and were less frequent in patients with
VS but no syndrome compared to patients with VSS.
This is emphasized by the latent class analysis itself showing
that VS does not present with specific clinical endopheno-
types and is classified predominantly on its severity (measured
with the burden of additional symptoms). Further studies
with objective measures on the levels of static such as severity
and disability scales as perceived by patients would be needed
to confirm this theory.
VS has 2 main comorbid conditions, migraine and
tinnitus.6–12 This strongly reported association suggests that
these 2 conditions might share some common pathophysio-
logic mechanism with VS. This hypothesis is substantiated by
a study that investigated brain metabolism in 17 patients with
VS with the use of [18F]-fluorodeoxyglucose-PET6 and
showed a hypermetabolism of the right lingual gyrus in
patients with VS. The area of the lingual gyrus corresponds to
Brodmann area 19 in the supplementary visual cortex and is pivotal
in processing complex downstream visual inputs. This area is also
involved in photophobia in migraine,13 which further corroborates
the concept of a shared pathophysiology betweenmigraine andVS,
possibly on the basis of a dysfunctional cortical mechanism com-
mon to both conditions.
Figure 2 Latent class analysis
(A) Latent class analysis performed on n = 1,060 patients with complete visual snow (VS) syndrome (VSS). Model fit criteria (table 6a) suggested that a 2-class
solution best explained the data. The latent classes, which separated the patients into groups based on additional visual symptom frequency, are shown
below. (B) Latent class analysis performed on n = 1,104 patients with complete VSS and VS without the syndrome. Patients with hallucinogen persisting
perception disorder were excluded. With the addition of patients with VS, an extra class was recovered (classes 1–3 shown below). However, the model still
separated the patients into groups based on additional visual symptom frequency only. BFEP = blue field entoptic phenomenon.
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Here, we confirmed the presence of these comorbid con-
ditions in a larger sample of patients with VS and demon-
strated that both conditions are associated with a worse
presentation of VS, defined by having more additional visual
symptoms. These comorbid conditions independently pre-
dicted the affinity to a severity class in the latent class model
and the number of additional symptoms in the ordinal lo-
gistic regression. This confirms the clinical and pathophys-
iologic importance of interaction between migraine, tinnitus,
and VS.
Tinnitus is a common disorder in the general population, with
a prevalence ranging between 5% and 25%.14–17 In the present
cohort, three-quarters of patients with VSS also had tinnitus,
suggesting a more than chance association between the 2
conditions. On a theoretical basis, VS and tinnitus represent 2
different manifestations of a similar disorder, which is the
perception of a sensory stimulus that is not present or is sub-
threshold. This neurobiological dysfunction would probably
point to a central neuronal mechanism, which could involve
aberrant sensory processing at the level of association cortices
or the thalamo-cortical network.
Given that tinnitus not only is more frequently present but also
predicts the severity of VS, it is possible that both disorders
share a common pathophysiologic mechanism, which, if suffi-
ciently active, can manifest clinically with both conditions. This
is what seems to happen in the majority of the patients in the
present study. This hypothesized mechanisms could involve
thalamo-cortical dysrhythmia18,19 and cortical disexcitability,
both of which have also been largely implicated in the context
of migraine pathophysiology.20,21 A possible confirmation of
such hypothesis comes from a very recent neurophysiologic
study that showed late visual evoked potential alterations in VS
highly suggestive of a visual association cortex dysfunction.22
Therefore, VS could represent an abnormality of sensory per-
ception, potentially involving multiple senses simultaneously.
A dishabituation mechanism common to migraine and VS
would explain the worsening of the VS condition when mi-
graine is present, which was found here and in previous
studies,6 as well as the strong comorbidity between them. The
presence of associated visual symptoms, enhanced entoptic
phenomena in particular, also potentially points to a disorder
of habituation and sensory processing, which allows the per-
ception of stimuli that are normally ignored by the brain. A
migrainous pathophysiology alone, however, is not sufficient
to explain the VS biology, primarily because of the chronic
nature of this disorder as opposed to the ictal features of
migraine, but also because most preventive migraine medi-
cation used empirically shows very little effect on VS.23
An important issue with VS is the assumption that it could be
due to HPPD. HPPD is a condition codified in DSM-V24 and
characterized by the re-experiencing of perceptual symptoms
(flashbacks), typically of the visual type, that follow the ces-
sation of the use of a hallucinogen and were experienced
during the intoxication.25 VS and HPPD indeed share some
clinical aspects, mostly characterized by the possibility of the
latter to manifest with visual static, palinopsia, flashes, and
other types of visual dysperceptions.5,25,26 Recent literature
seems to suggest that HPPD can be distinguished into 2 main
entities. In type 2 HPPD, the visual symptoms are constant or
nearly constant,27 consistent with the group of participants
from our cohort. In this study, to avoid any possible con-
founding overlap between HPPD and VS, we applied strict
criteria to identify VSS and VS. We considered 12 months
from the intake of any recreational drugs as an appropriate
time to exhaust possible effects of psychotropic substances on
the visual system. Any participants exposed within this time
frame were excluded from the VS groups. We believe this
allowed us to confirm that VS pathophysiology does not have
a connection with the use of recreational substances. Fur-
thermore, we were able to analyze a third group of patients
presenting with the VSS phenotype but for whom HPPD
could not be excluded. These participants were mostly male,
which might be due to substance use being generally more
common in men than women,28 and exhibited a later onset of
VS symptoms, in most cases with an abrupt start. However,
they fulfilled all remaining criteria for the syndrome and did
not differ from the main VSS group with regard to clinical VS
characteristics. Studies with confirmed HPPD would be
necessary to shed more light on the interesting overlap be-
tween VSS and drug intake, which may indeed represent
different aspects of a same disorder or 2 distinct conditions
with shared pathophysiologic mechanism. Our data do sug-
gest that VSS itself is not part of HPPD but rather that HPPD
can manifest in the VSS clinical spectrum.
There are important limitations to this work largely centered
around recruitment bias. First, recruited patients had con-
tacted the group directly to be involved in research; this is
likely to have selected participants at the more severe end of
the clinical spectrum. Nonetheless, most participants were
not seeking medical help when they contacted us, stating
that their primary reason for contact was simple curiosity
about their disorder. The fact that access to the study was
solely through the internet might have also biased toward
a younger population. The absence of an objective measure
of clinical severity is another limitation to this study; such
measures are yet to be developed. Finally, the methodology
was based on questionnaires completed remotely and relied
heavily on patient participation. The absence of a structured
interview conducted by a physician might have hindered the
clinical description in some cases. However, using a web-
based survey allowed broader geography that simply is not
feasible with in-person approaches. Moreover, the web-
based approach guaranteed the largest possible participation
in the study, which again would be very challenging if all
cases were to have had telephone interviews. The combi-
nation of detailed phenotyping in person and hypothesis
testing using broad, internet-based samples offers a powerful
tool, particularly when studying a relatively poorly charac-
terized condition.
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VSS is a geographically widely distributed neurologic disorder
that can be consistently defined by the current diagnostic
criteria. VSS does not manifest with specific endophenotypes
and likely represents a clinical continuum, with patients
ranging in different degrees of severity. On the severe end of
the spectrum, VS is more likely to present with its common
comorbid conditions, migraine and tinnitus. VSS is in-
dependent of the use of hallucinogenic substances, although
HPPD can manifest in the VS spectrum. In the future, further
studies are needed to enhance our understanding of the un-
derlying neurobiology of VS and consequently to move to-
ward an era of better management of the condition.
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